首页 > 最新文献

Turkiye Klinikleri Cardiovascular Sciences最新文献

英文 中文
Results of Patients Who Underwent Transcutaneous Radiofrequency in Lower Extremity Venous Insufficiency: Single Center Comparative Study 经皮射频治疗下肢静脉功能不全患者的结果:单中心比较研究
Q4 Medicine Pub Date : 2020-01-01 DOI: 10.5336/cardiosci.2020-79554
R. D. Atabey
{"title":"Results of Patients Who Underwent Transcutaneous Radiofrequency in Lower Extremity Venous Insufficiency: Single Center Comparative Study","authors":"R. D. Atabey","doi":"10.5336/cardiosci.2020-79554","DOIUrl":"https://doi.org/10.5336/cardiosci.2020-79554","url":null,"abstract":"","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89480036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Total LMCA Occlusion and Successful TAP Stenting: Which Strategy Should We Follow in STEMI? 急性LMCA全闭塞和成功的TAP支架植入:STEMI应该采用哪种策略?
Q4 Medicine Pub Date : 2020-01-01 DOI: 10.5336/cardiosci.2020-73421
Ömer Faruk Keskin, M. Demir, A. Iyisoy
84 The incidence of acute total left main coronary artery (LMCA) occlusion cannot be determined exactly because most of patients die before hospital arrival.1 This patient group is rarely encountered but mortality is very high due to being complicated by cardiogenic shock and lethal arrhythmia quickly.2 We report a case of a 40-year-old woman who was presented with acute anterolateral myocardial infarction and managed successfully with percutaneous intervention with TAP (T-stenting And small Protrusion) technique stenting. Acute Total LMCA Occlusion and Successful TAP Stenting: Which Strategy Should We Follow in STEMI?
84由于大多数患者在到达医院前死亡,因此急性左主干冠状动脉闭塞的发生率不能准确确定本组患者虽少见,但死亡率很高,可迅速并发心源性休克和致死性心律失常我们报告了一例40岁的女性,她被诊断为急性前外侧心肌梗死,并成功地通过经皮介入治疗TAP (t -支架置入和小突出)技术支架置入。急性LMCA全闭塞和成功的TAP支架植入:STEMI应该采用哪种策略?
{"title":"Acute Total LMCA Occlusion and Successful TAP Stenting: Which Strategy Should We Follow in STEMI?","authors":"Ömer Faruk Keskin, M. Demir, A. Iyisoy","doi":"10.5336/cardiosci.2020-73421","DOIUrl":"https://doi.org/10.5336/cardiosci.2020-73421","url":null,"abstract":"84 The incidence of acute total left main coronary artery (LMCA) occlusion cannot be determined exactly because most of patients die before hospital arrival.1 This patient group is rarely encountered but mortality is very high due to being complicated by cardiogenic shock and lethal arrhythmia quickly.2 We report a case of a 40-year-old woman who was presented with acute anterolateral myocardial infarction and managed successfully with percutaneous intervention with TAP (T-stenting And small Protrusion) technique stenting. Acute Total LMCA Occlusion and Successful TAP Stenting: Which Strategy Should We Follow in STEMI?","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72519521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A New Risk Factor for Cardiometabolic Syndrome: Chrononutrition 心脏代谢综合征的新危险因素:时间营养
Q4 Medicine Pub Date : 2020-01-01 DOI: 10.5336/cardiosci.2020-75175
E. Arslan, Tuğçe Özlü, E. B. Kenger, Can Ergün
{"title":"A New Risk Factor for Cardiometabolic Syndrome: Chrononutrition","authors":"E. Arslan, Tuğçe Özlü, E. B. Kenger, Can Ergün","doi":"10.5336/cardiosci.2020-75175","DOIUrl":"https://doi.org/10.5336/cardiosci.2020-75175","url":null,"abstract":"","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72710050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major Complications and Nursing Care of Patients Implanted Left Ventricular Assist Device 植入左心室辅助装置患者的主要并发症及护理
Q4 Medicine Pub Date : 2020-01-01 DOI: 10.5336/cardiosci.2020-75535
F. Korkmaz, Nihal Çeli̇ktürk
{"title":"Major Complications and Nursing Care of Patients Implanted Left Ventricular Assist Device","authors":"F. Korkmaz, Nihal Çeli̇ktürk","doi":"10.5336/cardiosci.2020-75535","DOIUrl":"https://doi.org/10.5336/cardiosci.2020-75535","url":null,"abstract":"","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91323328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Pharmacomechanical Thrombolytic Treatment in Deep Vein Thrombosis Associated with Behçet's Disease: One-Year Results 药物力学溶栓治疗与behet病相关的深静脉血栓:一年的结果
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.5336/cardiosci.2018-63041
Ümit Arslan, E. Calik
{"title":"The Use of Pharmacomechanical Thrombolytic Treatment in Deep Vein Thrombosis Associated with Behçet's Disease: One-Year Results","authors":"Ümit Arslan, E. Calik","doi":"10.5336/cardiosci.2018-63041","DOIUrl":"https://doi.org/10.5336/cardiosci.2018-63041","url":null,"abstract":"","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"315 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78047669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Serum Lactate and Lactate Clearence on Mortality in Cardiac Surgery Patients 血清乳酸及乳酸清除率对心脏手术患者死亡率的影响
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.5336/cardiosci.2019-70462
G. Patmano, T. Bingöl, M. Tercan, A. Kaya
mic perfusion and oxygenation during cardiac surgery. Tissue hypoperfusion due to circulatory failure during CPB may lead to an increase in lactate levels secondary to anaerobic metabolism.1,2 Studies have shown that high lactate levels are associated with poor outcomes in many clinical conditions, including cardiac surgery.3 Blood lactate levels are also Turkiye Klinikleri J Cardiovasc Sci. 2019;31(3):155-61
心脏手术过程中的微灌注和氧合。CPB期间由于循环衰竭引起的组织灌注不足可能导致继发于无氧代谢的乳酸水平增加。1,2研究表明,高乳酸水平与许多临床情况的不良预后相关,包括心脏手术血乳酸水平的变化[J] .中华心血管病杂志,2019;31(3):155-61
{"title":"The Effect of Serum Lactate and Lactate Clearence on Mortality in Cardiac Surgery Patients","authors":"G. Patmano, T. Bingöl, M. Tercan, A. Kaya","doi":"10.5336/cardiosci.2019-70462","DOIUrl":"https://doi.org/10.5336/cardiosci.2019-70462","url":null,"abstract":"mic perfusion and oxygenation during cardiac surgery. Tissue hypoperfusion due to circulatory failure during CPB may lead to an increase in lactate levels secondary to anaerobic metabolism.1,2 Studies have shown that high lactate levels are associated with poor outcomes in many clinical conditions, including cardiac surgery.3 Blood lactate levels are also Turkiye Klinikleri J Cardiovasc Sci. 2019;31(3):155-61","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85088724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Sacubitril/Valsartan on Clinical and Laboratory Findings Comparatively in Ischemic and Non-Ischemic Heart Failure Patients 沙比利/缬沙坦对缺血性和非缺血性心力衰竭患者临床和实验室检查的影响
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.5336/cardiosci.2019-66657
Tuğba Kemaloğlu Öz, T. Kıvrak, T. Gürol, R. Zehir, Ö. Soylu, B. Dağdeviren
{"title":"The Effect of Sacubitril/Valsartan on Clinical and Laboratory Findings Comparatively in Ischemic and Non-Ischemic Heart Failure Patients","authors":"Tuğba Kemaloğlu Öz, T. Kıvrak, T. Gürol, R. Zehir, Ö. Soylu, B. Dağdeviren","doi":"10.5336/cardiosci.2019-66657","DOIUrl":"https://doi.org/10.5336/cardiosci.2019-66657","url":null,"abstract":"","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83616273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bleeding Due to Warfarin Treatment: Five Years of Experience 华法林治疗后出血:5年经验
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.5336/cardiosci.2019-65895
S. Koçak, B. Ertekin, E. Öztürk, Z. D. Dündar, T. Acar, A. S. Girişgin
ABS TRACT Objective: The aim of the study was to determine the factors contributing to the development of bleeding and mortality in patients admitted to emergency department with any nontraumatic bleeding (major or minor) complaint while under warfarin therapy. Material and Methods: Patients who admitted to the emergency department of a university hospital between 2009 and 2013 due to bleeding complications during warfarin treatment were included in the study which was conducted in a prospective and observational design. The demographic characteristics of the patients, the reasons for using warfarin, the types and localizations of the bleedings, the treatments applied, the duration of hospitalization and mortality data were recorded. The factors that are likely to be effective on bleeding and mortality (age, hemodynamic status on admission, initial INR levels, warfarin dose, etc.) were analyzed comparatively. SPSS version 16.0 program was used for statistical analysis and p<0.05 was considered statistically significant. Results: A total of 518 patients were enrolled in the study. The mean age of the patients was 64.19±13.28 years, 229 (44.2%) of the patients were male. More than half of the patients were over 65 years of age, the most common indication for warfarin was heart valve disease and atrial fibrillation, and the most mortal bleeding type was gastrointestinal bleeding. There was no correlation between the first INR levels on admission and the bleeding severity and mortality (p=0.577, p=0.788). The most significant indicator of mortality was hemodynamic instability during admission. Systolic and diastolic arterial blood pressure and haemoglobin levels were significantly lower (p=0.004, p=0.023, p=0.001, respectively) in nonsurvivors, whereas pulse and shock index were significantly higher (p<0.001, p<0.001). Conclusion: Patients under warfarin treatment admit to emergency services with major or minor bleeding independently from INR levels. Especially, patients aged 65 and over are at risk. The most significant indicator of mortality appears to be hemodynamic instability during admission.
目的:本研究的目的是确定在华法林治疗期间因任何非创伤性出血(或大或小)主因而入院急诊科的患者发生出血和死亡的因素。材料与方法:本研究采用前瞻性观察设计,纳入2009 - 2013年间因华法林治疗期间出血并发症而入住某大学附属医院急诊科的患者。记录患者的人口统计学特征、使用华法林的原因、出血类型和部位、使用的治疗方法、住院时间和死亡率数据。比较分析可能影响出血和死亡率的因素(年龄、入院时血流动力学状态、初始INR水平、华法林剂量等)。采用SPSS 16.0版软件进行统计学分析,p<0.05为差异有统计学意义。结果:共有518例患者入组。患者平均年龄64.19±13.28岁,男性229例(44.2%)。超过一半的患者年龄在65岁以上,华法林最常见的适应症是心瓣膜疾病和心房颤动,最致命的出血类型是胃肠道出血。入院时首次INR水平与出血严重程度和死亡率无相关性(p=0.577, p=0.788)。死亡率最重要的指标是入院时血流动力学不稳定。非幸存者的收缩压和舒张压及血红蛋白水平显著降低(p=0.004, p=0.023, p=0.001),而脉搏和休克指数显著升高(p<0.001, p<0.001)。结论:接受华法林治疗的患者因大出血或小出血而入院,与INR水平无关。特别是65岁及以上的患者处于危险之中。最重要的死亡率指标似乎是入院时的血流动力学不稳定。
{"title":"Bleeding Due to Warfarin Treatment: Five Years of Experience","authors":"S. Koçak, B. Ertekin, E. Öztürk, Z. D. Dündar, T. Acar, A. S. Girişgin","doi":"10.5336/cardiosci.2019-65895","DOIUrl":"https://doi.org/10.5336/cardiosci.2019-65895","url":null,"abstract":"ABS TRACT Objective: The aim of the study was to determine the factors contributing to the development of bleeding and mortality in patients admitted to emergency department with any nontraumatic bleeding (major or minor) complaint while under warfarin therapy. Material and Methods: Patients who admitted to the emergency department of a university hospital between 2009 and 2013 due to bleeding complications during warfarin treatment were included in the study which was conducted in a prospective and observational design. The demographic characteristics of the patients, the reasons for using warfarin, the types and localizations of the bleedings, the treatments applied, the duration of hospitalization and mortality data were recorded. The factors that are likely to be effective on bleeding and mortality (age, hemodynamic status on admission, initial INR levels, warfarin dose, etc.) were analyzed comparatively. SPSS version 16.0 program was used for statistical analysis and p<0.05 was considered statistically significant. Results: A total of 518 patients were enrolled in the study. The mean age of the patients was 64.19±13.28 years, 229 (44.2%) of the patients were male. More than half of the patients were over 65 years of age, the most common indication for warfarin was heart valve disease and atrial fibrillation, and the most mortal bleeding type was gastrointestinal bleeding. There was no correlation between the first INR levels on admission and the bleeding severity and mortality (p=0.577, p=0.788). The most significant indicator of mortality was hemodynamic instability during admission. Systolic and diastolic arterial blood pressure and haemoglobin levels were significantly lower (p=0.004, p=0.023, p=0.001, respectively) in nonsurvivors, whereas pulse and shock index were significantly higher (p<0.001, p<0.001). Conclusion: Patients under warfarin treatment admit to emergency services with major or minor bleeding independently from INR levels. Especially, patients aged 65 and over are at risk. The most significant indicator of mortality appears to be hemodynamic instability during admission.","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82674224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Proportional Serum Lipid Parameters in Coronary Slow Flow Phenomenon 冠状动脉慢血流现象的比例血脂参数
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.5336/CARDIOSCI.2018-63794
Belma Kalaycı, S. Kalaycı, F. Kokturk
ABS TRACT Objective: The association between serum lipid parameters and coronary slow-flow (CSF) phenomenon has been searched previously. The aim of our study was to determine the association between proportional serum lipid parameters and CSF. Material and Methods: We enrolled 93 stable patients randomly who had undergone coronary angiography and had near-normal coronary arteries with normal and slow coronary flow. Demographic, clinical and laboratory data were recorded retrospectively. Coronary flow velocity was evaluated by TIMI frame count (TFC). CFS phenomenon was defined as a TFC greater than 27 frames. Corrected TFC was calculated for the left anterior descending coronary artery. Results: Fifty four patients were in CSF group and 39 patients were in control group. The mean age of the patients in CSF group was significantly higher than control group (55.4±9.5 vs. 50.5±9.8 years, p= 0.019). Triglyceride (TG) levels was found higher in CSF group than control group (187.3±103.4 mg/dl, 125.3±63.8 mg/dl, p<0.001). Total cholesterol to high density lipoprotein cholesterol ratio (TC/HDL-c), TG/HDL-c, low density lipoprotein cholesterol to HDL-c ratio (LDL-c/HDL-c) and non-HDL-c levels were significantly higher in CSF group (p=0.007, p=0.004, p=0.044, p=0.018, respectively). TG and TG/HDL-c were found correlated with TFC (r=0.280, r=0.262, respectively). In multivariate logistic regression analysis age, smoking and TG were found statistically significant to predict of CSF. TG was found most associated with the presence of CSF (OR: 7.516, p=0.001). Conclusion: Higher TG, TC/HDL-c, TG/HDL-c, LDLc/HDL-c and non-HDL-c levels were related with CSF phenomenon.
目的:血脂参数与冠状动脉慢血流(CSF)现象之间的关系已被研究过。我们研究的目的是确定比例血脂参数和脑脊液之间的关系。材料和方法:我们随机招募了93例稳定的患者,他们都做过冠状动脉造影,冠状动脉接近正常,冠状动脉血流正常和缓慢。回顾性记录人口统计学、临床和实验室数据。采用TIMI帧计数(TFC)评价冠状动脉血流速度。CFS现象定义为TFC大于27帧。计算左冠状动脉前降支校正TFC。结果:脑脊液组54例,对照组39例。脑脊液组患者平均年龄明显高于对照组(55.4±9.5∶50.5±9.8,p= 0.019)。脑脊液组甘油三酯(TG)水平高于对照组(187.3±103.4 mg/dl, 125.3±63.8 mg/dl, p<0.001)。CSF组总胆固醇与高密度脂蛋白胆固醇之比(TC/HDL-c)、TG/HDL-c、低密度脂蛋白胆固醇与HDL-c之比(LDL-c/HDL-c)及非HDL-c水平均显著升高(p=0.007、p=0.004、p=0.044、p=0.018)。TG和TG/HDL-c与TFC相关(r=0.280, r=0.262)。多因素logistic回归分析发现,年龄、吸烟和TG对脑脊液的预测有统计学意义。发现TG与CSF的存在最相关(OR: 7.516, p=0.001)。结论:高TG、TC/HDL-c、TG/HDL-c、ldl /HDL-c及非HDL-c水平与脑脊液现象有关。
{"title":"Proportional Serum Lipid Parameters in Coronary Slow Flow Phenomenon","authors":"Belma Kalaycı, S. Kalaycı, F. Kokturk","doi":"10.5336/CARDIOSCI.2018-63794","DOIUrl":"https://doi.org/10.5336/CARDIOSCI.2018-63794","url":null,"abstract":"ABS TRACT Objective: The association between serum lipid parameters and coronary slow-flow (CSF) phenomenon has been searched previously. The aim of our study was to determine the association between proportional serum lipid parameters and CSF. Material and Methods: We enrolled 93 stable patients randomly who had undergone coronary angiography and had near-normal coronary arteries with normal and slow coronary flow. Demographic, clinical and laboratory data were recorded retrospectively. Coronary flow velocity was evaluated by TIMI frame count (TFC). CFS phenomenon was defined as a TFC greater than 27 frames. Corrected TFC was calculated for the left anterior descending coronary artery. Results: Fifty four patients were in CSF group and 39 patients were in control group. The mean age of the patients in CSF group was significantly higher than control group (55.4±9.5 vs. 50.5±9.8 years, p= 0.019). Triglyceride (TG) levels was found higher in CSF group than control group (187.3±103.4 mg/dl, 125.3±63.8 mg/dl, p<0.001). Total cholesterol to high density lipoprotein cholesterol ratio (TC/HDL-c), TG/HDL-c, low density lipoprotein cholesterol to HDL-c ratio (LDL-c/HDL-c) and non-HDL-c levels were significantly higher in CSF group (p=0.007, p=0.004, p=0.044, p=0.018, respectively). TG and TG/HDL-c were found correlated with TFC (r=0.280, r=0.262, respectively). In multivariate logistic regression analysis age, smoking and TG were found statistically significant to predict of CSF. TG was found most associated with the presence of CSF (OR: 7.516, p=0.001). Conclusion: Higher TG, TC/HDL-c, TG/HDL-c, LDLc/HDL-c and non-HDL-c levels were related with CSF phenomenon.","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79330028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Management of a Hemorrhagic Pleural Effusion Under Apixaban Treatment in an Octogenarian Patient 阿哌沙班治疗一例八十多岁患者出血性胸腔积液的处理
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.5336/CARDIOSCI.2018-63000
D. Omaygenç, M. Omaygenc
Anticoagulant agents; Apixaban; atrial fibrillation; hemothorax; pleural effusion ÖÖZZEETT Mevcut verilerin gerçek dünya serileriyle de desteklenmesinden sonra Non-Vitamin K oral antikoagülanların (NOAKlar), K vitamini antagonistlerine kıyasla inme riskinin azaltılmasında en eşit etkinliği sahip olduğu daha olduğu 72 alınmıştır. Olguda anti- koagülasyonun etkisinin kaldırılması transfüzyon
{"title":"Management of a Hemorrhagic Pleural Effusion Under Apixaban Treatment in an Octogenarian Patient","authors":"D. Omaygenç, M. Omaygenc","doi":"10.5336/CARDIOSCI.2018-63000","DOIUrl":"https://doi.org/10.5336/CARDIOSCI.2018-63000","url":null,"abstract":"Anticoagulant agents; Apixaban; atrial fibrillation; hemothorax; pleural effusion ÖÖZZEETT Mevcut verilerin gerçek dünya serileriyle de desteklenmesinden sonra Non-Vitamin K oral antikoagülanların (NOAKlar), K vitamini antagonistlerine kıyasla inme riskinin azaltılmasında en eşit etkinliği sahip olduğu daha olduğu 72 alınmıştır. Olguda anti- koagülasyonun etkisinin kaldırılması transfüzyon","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73875090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkiye Klinikleri Cardiovascular Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1